Invesco

Invesco’s ARS Pharmaceuticals SPRY Stock Holding History

Invesco’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$307K	Buy	38,186 +956	+3%	+$9.16K	﹤0.01%	3332
2025 Q4	$434K	Sell	37,230 -2,879	-7%	-$28K	﹤0.01%	3251
2025 Q3	$403K	Sell	40,109 -77,391	-66%	-$1.11M	﹤0.01%	3309
2025 Q2	$2.05M	Buy	117,500 +87,551	+292%	+$1.26M	﹤0.01%	2571
2025 Q1	$377K	Buy	29,949 +9,961	+50%	+$120K	﹤0.01%	3268
2024 Q4	$211K	Sell	19,988 -105,623	-84%	-$1.48M	﹤0.01%	3503
2024 Q3	$1.82M	Sell	125,611 -294,964	-70%	-$3.51M	﹤0.01%	2644
2024 Q2	$3.58M	Buy	420,575 +9,203	+2%	+$81.7K	﹤0.01%	2350
2024 Q1	$4.2M	Buy	411,372 +396,817	+2,726%	+$2.96M	﹤0.01%	2336
2023 Q4	$79.8K	Buy	14,555 +1,698	+13%	+$7.44K	﹤0.01%	3713
2023 Q3	$48.6K	Buy	12,857 +80	+0.6%	+$525	﹤0.01%	3798
2023 Q2	$85.6K	Sell	12,777 -234,212	-95%	-$1.56M	﹤0.01%	3756
2023 Q1	$1.61M	Buy	246,989 +56,127	+29%	+$431K	﹤0.01%	2725
2022 Q4	$1.63M	Buy	+190,862	New	+$1.24M	﹤0.01%	2721

Other funds holding SPRY

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return